---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 23, 2017 Category: Molecular Biology Source Type: research

Flow cytometry vs optical microscopy in the evaluation of the genotoxic potential of xenobiotic compounds
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 22, 2017 Category: Molecular Biology Authors: MoniaLenzi , VeronicaCocchi , PatriziaHrelia Source Type: research

---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 22, 2017 Category: Molecular Biology Source Type: research

The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 11, 2017 Category: Molecular Biology Authors: MarieToft ‐Petersen , AnneStidsholt Roug , TrinePlesner , LeneEbbesen , Gordon D.Brown , LineNederby Source Type: research

---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 11, 2017 Category: Molecular Biology Source Type: research

The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia
ConclusionsIdentification and enumeration of basophils is of high relevance in diagnostic hematology and immunology. We here show that CLEC12A in a simple FCM assay consistently marks basophils. Importantly, as basophils are characterized by a CD45lowSSClow profile similar to the “blast‐gate” used for the evaluation of hematological disorders, awareness of minor normal CLEC12A+ subpopulations is crucial when using CLEC12A as a minimal residual disease marker in myeloid malignancies. © 2017 International Clinical Cytometry Society (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 11, 2017 Category: Molecular Biology Authors: Marie Toft ‐Petersen, Anne Stidsholt Roug, Trine Plesner, Lene Ebbesen, Gordon D. Brown, Line Nederby Tags: Original Article Source Type: research

High ‐dimensional single cell mapping of cerium distribution in the lung immune microenvironment of an active smoker
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 7, 2017 Category: Molecular Biology Authors: Adeeb H.Rahman , YonitLavin , SomaKobayashi , AndrewLeader , MiriamMerad Source Type: research

---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 7, 2017 Category: Molecular Biology Source Type: research

Evaluation of primary mediastinal large B cell lymphoma by flow cytometry
Cytometry Part B: Clinical Cytometry, EarlyView. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 4, 2017 Category: Molecular Biology Authors: SindhuCherian , Jonathan R.Fromm Source Type: research

---
Cytometry Part B: Clinical Cytometry, Ahead of Print. (Source: Cytometry Part B: Clinical Cytometry)
Source: Cytometry Part B: Clinical Cytometry - August 4, 2017 Category: Molecular Biology Source Type: research